Oncolytics Biotech
ONCY
#9206
Rank
A$0.16 B
Marketcap
A$1.51
Share price
3.80%
Change (1 day)
18.64%
Change (1 year)

Earnings for Oncolytics Biotech (ONCY)

Earnings in 2025 (TTM): -A$38.66 Million

According to Oncolytics Biotech 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -A$38.12 Million a decrease over its 2023 earnings that were of -A$37.73 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Oncolytics Biotech from 2001 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$38.66 Million1.43%
2024 -A$38.12 Million1.01%
2023 -A$37.73 Million23.39%
2022 -A$30.58 Million-1.98%
2021 -A$31.2 Million9.1%
2020 -A$28.6 Million22.64%
2019 -A$23.32 Million22.78%
2018 -A$18.99 Million4.1%
2017 -A$18.24 Million4.87%
2016 -A$17.4 Million8.75%
2015 -A$16 Million-37.06%
2014 -A$25.41 Million-26.2%
2013 -A$34.44 Million-37.39%
2012 -A$55 Million28.8%
2011 -A$42.7 Million46.02%
2010 -A$29.25 Million35.64%
2009 -A$21.56 Million-14.2%
2008 -A$25.13 Million-0.52%
2007 -A$25.26 Million24.6%
2006 -A$20.28 Million45.34%
2005 -A$13.95 Million-11.8%
2004 -A$15.82 Million115.36%
2003 -A$7.35 Million13.86%
2002 -A$6.45 Million-5.45%
2001 -A$6.82 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Aeterna Zentaris
AEZS
-A$8.22 Million-77.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$33.70 B-90,559.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$12.03 B-32,390.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$2.65 B-7,223.05%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
AVEO Oncology
AVEO
-A$43.5 Million 16.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Mirati Therapeutics
MRTX
-A$1.15 Billion 2,974.61%๐Ÿ‡บ๐Ÿ‡ธ USA